Accordingly, secreted IL6 and IL6 promoter activity was elevated in cultured cells derived from tumours and metastases as well as in the serum of mice bearing HT-resistant xenografts (treatment with tamoxifen or fulvestrant; Fig. 1e and Supplementary Fig. 1h,i). The gene discussed is IL6; the disease is neoplasm.